GlassScriptPhysician profile
Constantine S Kyramarios
NPI 1033124888
$1,088.29
in general payments reported to CMS, 2019-2025
15 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $163 · 2021: $50.59 · 2022: $33.25 · 2023: $158 · 2024: $252 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $390.77 | 2019-2025 | Viaflow, Darco, Citrefix |
| Kerecis Limited | $165.98 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Sandoz INC. | $130.79 | 2019-2020 | |
| Organogenesis INC. | $111.27 | 2019-2022 | |
| Treace Medical Concepts, INC. | $49.44 | 2023-2025 | |
| Abbvie INC. | $44.62 | 2023-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $44.06 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $38.66 | 2025 | Purified Cortrophin Gel |
| Smith+Nephew, INC. | $21.40 | 2020 | |
| Zimmer Biomet Holdings, INC. | $17.76 | 2019 | |
| Baudax Bio INC. | $16.85 | 2020 | |
| Paragon 28, INC. | $15.67 | 2024 | Precision Mis Bunion |
| Wright Medical Technology, INC. | $15.17 | 2019 | |
| Djo, LLC | $13.85 | 2025 | Cmf |
| Bioventus LLC | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Kyramarios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.